US Stock MarketDetailed Quotes

IMMX Immix Biopharma

Watchlist
  • 2.190
  • +0.110+5.29%
Close Jul 22 16:00 ET
  • 2.220
  • +0.030+1.37%
Post 17:40 ET
57.85MMarket Cap-2354P/E (TTM)

Immix Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Immix Biopharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.22

-22.22%
Analyst Rating

Buy

Jul 1, 2024

Immix Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Immix Biopharma Earnings Reports

  • Immix Biopharma | 10-Q: Quarterly report

    May 9 16:33 ET

  • Immix Biopharma | 10-K: Annual report

    Mar 29 16:09 ET

  • Immix Biopharma: Q3 2023 Earnings Report

    Nov 9, 2023 20:24 ET

  • Immix Biopharma | 10-Q: Q2 2023 Earnings Report

    Aug 11, 2023 16:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 1, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg